George Chi
Plus aucun poste en cours
Profil
George Chi served as the Chief Executive Officer of TH Plasma and Finance Director at Unilever Plc.
He also worked as the Vice President-Finance at Flavors Holdings, Inc. In addition, he held the position of Chief Financial Officer at BPL Plasma, Inc. from 2014 to 2016 and served as the Chief Financial & Accounting Officer at CASI Pharmaceuticals, Inc. from 2018 to 2020.
He will be the Chief Financial Officer at OncoSec Medical, Inc. in 2022 and 2023.
Mr. Chi received his undergraduate degree from Tsinghua University in 1993 and his MBA from Yale School of Management in 2003.
Anciens postes connus de George Chi
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Director of Finance/CFO | 12/06/2023 |
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Director of Finance/CFO | 21/02/2020 |
BPL Plasma, Inc.
 BPL Plasma, Inc. Medical/Nursing ServicesHealth Services BPL Plasma, Inc. provides blood plasma collection and supply services. It support the creation and manufacturing of lifesaving drug therapies by supplying plasma to people in need. The company is headquartered in Austin, TX. | Director of Finance/CFO | 01/01/2016 |
| UNILEVER PLC | Director of Finance/CFO | - |
| TH Plasma | Chief Executive Officer | - |
Formation de George Chi
| Tsinghua University | Undergraduate Degree |
| Yale School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| UNILEVER PLC | Consumer Non-Durables |
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| Entreprise privées | 4 |
|---|---|
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |
Flavors Holdings, Inc.
 Flavors Holdings, Inc. Food: Specialty/CandyConsumer Non-Durables Flavors Holdings, Inc. operates as a holding company, which manufacturers tabletop sweeteners. The firm markets its sweeteners under its flagship brands Equal, Canderel and Pure. The company is headquartered in New York, NY. | Consumer Non-Durables |
BPL Plasma, Inc.
BPL Plasma, Inc. Medical/Nursing ServicesHealth Services BPL Plasma, Inc. provides blood plasma collection and supply services. It support the creation and manufacturing of lifesaving drug therapies by supplying plasma to people in need. The company is headquartered in Austin, TX. | Health Services |
| TH Plasma |
